Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, ...
Attend any eDiscovery technology conference or demo today, and you’ll likely hear some variation of: “Search terms are ...
Recent polls and forecasts show Democrats have a chance to gain ground in Alaska in this year's midterm elections.
Higher short-term weight variability during the first 12 weeks is linked to less subsequent long-term weight loss in healthy ...
PE funds in Japan have too much capital and not enough deal flow. Activists often drive companies into PE funds' arms.
About half a million samples are collected from over-50s in Scotland each year in a highly successful NHS program that ...
From school project to breakthrough: how a teenager built an AI tool that reads the eye to detect autism and ADHD.
If you want to hit your target, you need three things: a gun, a target and a method by which to hit that target with that gun ...
W HEN ERIC STALLARD, an actuary and academic, began looking into the incidence of dementia among elderly Americans, he was so ...
Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...
The TWC ivermectin/mebendazole “study” — Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: ...
Successful Type B RDEP Meeting confirms FDA alignment on pivotal Phase 3 study designFDA indicates Opus Genetics may submit a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results